| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
36,263 |
33,421 |
$3.25M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
29,789 |
25,822 |
$2.07M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
8,301 |
7,891 |
$780K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,628 |
3,247 |
$641K |
| 80053 |
Comprehensive metabolic panel |
27,901 |
22,551 |
$595K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,239 |
2,693 |
$361K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,883 |
4,199 |
$359K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
3,016 |
2,812 |
$327K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,731 |
1,519 |
$221K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,579 |
564 |
$113K |
| G0378 |
Hospital observation service, per hour |
4,266 |
2,278 |
$111K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,254 |
1,146 |
$93K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,164 |
2,602 |
$93K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
511 |
466 |
$86K |
| 76830 |
Ultrasound, transvaginal |
1,161 |
1,068 |
$83K |
| 87070 |
|
3,992 |
3,789 |
$79K |
| 87400 |
|
11,625 |
11,063 |
$73K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,274 |
2,014 |
$68K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,367 |
1,223 |
$65K |
| 86850 |
|
2,628 |
2,155 |
$64K |
| 81001 |
|
10,797 |
9,470 |
$58K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
11,647 |
10,963 |
$57K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,415 |
1,315 |
$51K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,186 |
861 |
$43K |
| 71045 |
Radiologic examination, chest; single view |
11,307 |
9,816 |
$40K |
| 81003 |
|
5,758 |
5,143 |
$40K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,928 |
3,535 |
$37K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,134 |
1,060 |
$36K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
912 |
802 |
$36K |
| 84703 |
|
2,160 |
2,019 |
$36K |
| 76818 |
|
985 |
711 |
$35K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,056 |
845 |
$32K |
| 85027 |
|
31,982 |
25,396 |
$31K |
| 71046 |
Radiologic examination, chest; 2 views |
3,257 |
3,006 |
$28K |
| 76801 |
|
784 |
684 |
$28K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
489 |
432 |
$25K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,472 |
4,467 |
$25K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,877 |
1,711 |
$24K |
| 74018 |
|
1,169 |
1,075 |
$20K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
292 |
256 |
$20K |
| 84702 |
|
3,410 |
2,798 |
$19K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
13,563 |
11,156 |
$19K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
402 |
370 |
$19K |
| 73610 |
|
1,005 |
920 |
$19K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
169 |
50 |
$17K |
| 87077 |
|
1,636 |
1,444 |
$16K |
| 73630 |
|
1,067 |
999 |
$16K |
| 73564 |
|
985 |
856 |
$15K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
15,446 |
13,283 |
$15K |
| 73130 |
|
716 |
668 |
$14K |
| 87420 |
|
2,301 |
2,226 |
$13K |
| A9270 |
Non-covered item or service |
7,012 |
1,727 |
$12K |
| 82731 |
|
82 |
81 |
$12K |
| 73110 |
|
562 |
524 |
$11K |
| 73030 |
|
574 |
476 |
$10K |
| 84112 |
|
210 |
192 |
$10K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
582 |
488 |
$8K |
| 81025 |
|
2,960 |
2,702 |
$7K |
| 86900 |
|
3,065 |
2,530 |
$7K |
| 70480 |
|
259 |
228 |
$7K |
| 84484 |
|
7,187 |
4,836 |
$7K |
| 12001 |
|
71 |
66 |
$6K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
74 |
63 |
$6K |
| 12011 |
|
61 |
56 |
$5K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
609 |
180 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,374 |
4,205 |
$4K |
| 85610 |
|
6,300 |
5,226 |
$4K |
| G0383 |
Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
28 |
25 |
$4K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,117 |
3,612 |
$4K |
| 86901 |
|
3,014 |
2,483 |
$3K |
| 76775 |
|
55 |
50 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
7,283 |
5,952 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,605 |
4,547 |
$3K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
262 |
111 |
$3K |
| 87040 |
|
2,718 |
2,139 |
$3K |
| 87210 |
|
324 |
311 |
$2K |
| 83735 |
|
5,387 |
4,175 |
$2K |
| 82570 |
|
301 |
241 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
480 |
386 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,536 |
1,374 |
$2K |
| 73090 |
|
67 |
63 |
$2K |
| 83690 |
|
5,560 |
4,915 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
225 |
157 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,456 |
3,808 |
$2K |
| 93970 |
|
68 |
61 |
$2K |
| 86140 |
|
1,510 |
1,296 |
$2K |
| 73080 |
|
128 |
119 |
$2K |
| 85730 |
|
4,364 |
3,722 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
192 |
179 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,787 |
2,093 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,283 |
3,513 |
$1K |
| 80061 |
Lipid panel |
646 |
559 |
$1K |
| 97161 |
|
46 |
44 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
165 |
153 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,547 |
1,970 |
$973.02 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
168 |
135 |
$920.29 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
87 |
70 |
$784.29 |
| 85379 |
|
540 |
506 |
$771.76 |
| 72110 |
|
59 |
56 |
$755.08 |
| C1769 |
Guide wire |
29 |
24 |
$708.41 |
| J7050 |
Infusion, normal saline solution, 250 cc |
918 |
631 |
$690.16 |
| 82150 |
|
2,286 |
2,058 |
$646.15 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
195 |
165 |
$619.23 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,216 |
946 |
$598.35 |
| 73590 |
|
27 |
27 |
$592.43 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
429 |
339 |
$560.12 |
| 87186 |
|
1,349 |
1,169 |
$484.22 |
| 84439 |
|
131 |
118 |
$419.57 |
| 85652 |
|
624 |
500 |
$413.26 |
| 73502 |
|
30 |
25 |
$369.49 |
| 83880 |
|
1,567 |
1,342 |
$366.28 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
210 |
190 |
$342.18 |
| 84145 |
|
90 |
78 |
$340.34 |
| 97116 |
|
28 |
12 |
$311.93 |
| J1644 |
Injection, heparin sodium, per 1000 units |
29 |
13 |
$303.01 |
| 83605 |
|
1,880 |
1,521 |
$282.41 |
| 36415 |
Collection of venous blood by venipuncture |
438 |
343 |
$273.61 |
| 84156 |
|
319 |
242 |
$265.32 |
| 84100 |
|
1,443 |
1,056 |
$258.30 |
| 80076 |
|
75 |
69 |
$258.04 |
| 90714 |
|
198 |
173 |
$223.82 |
| 93971 |
|
12 |
12 |
$207.26 |
| J2704 |
Injection, propofol, 10 mg |
144 |
103 |
$175.52 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,985 |
1,847 |
$82.30 |
| 82805 |
|
14 |
12 |
$81.08 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
210 |
147 |
$67.38 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
74 |
25 |
$62.64 |
| 96376 |
|
1,247 |
838 |
$58.54 |
| 83615 |
|
76 |
63 |
$18.71 |
| S0028 |
Injection, famotidine, 20 mg |
792 |
702 |
$10.48 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,609 |
1,339 |
$5.55 |
| 82248 |
|
34 |
24 |
$1.48 |
| 84132 |
|
30 |
25 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
526 |
438 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,137 |
961 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
207 |
166 |
$0.00 |
| J3490 |
Unclassified drugs |
128 |
78 |
$0.00 |
| 87147 |
|
14 |
13 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
74 |
71 |
$0.00 |
| 86308 |
|
12 |
12 |
$0.00 |
| 82550 |
|
45 |
38 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
114 |
39 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
13 |
12 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
51 |
40 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
12 |
12 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
309 |
180 |
$0.00 |
| C1758 |
Catheter, ureteral |
44 |
40 |
$0.00 |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
17 |
15 |
$0.00 |
| 00840 |
|
27 |
27 |
$0.00 |
| 82375 |
|
14 |
12 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
18 |
13 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
99 |
86 |
$0.00 |
| 29125 |
|
15 |
15 |
$0.00 |